High dose bolus methylprednisolone for the treatment of acute graft versus host disease (original) (raw)

Summary

Nineteen patients with acute graft versus host disease (GvHD) following bone marrow transplantation (BMT) were treated with high dose bolus 6-methylprednisolone (BMPr), at the dose of 20 mg/kg/day i.v. for the first 3 days, 10 mg/kg/day i.v. for the following 4 days, and then at doses gradually tapered down to 1 mg/kg/day. All patients except one, who was given preventive BMPr 5 mg/kg/day i.v. on alternate days, were placed on preventive methotrexate therapy after BMT. Sixteen patients were grafted with an HLA matched, and three patients with an HLA mismatched marrow.

Overall complete response rate in the HLA matched group was 43%, with an additional 50% showing a partial response. In the HLA mismatched group there were no responses and all three patients proved refractory to BMPr.

With respect to organ involvement the complete and partial response rates were respectively 50% and 33% in the skin, 36% and 28% in the liver, 18% and 55% in the gut.

Six of sixteen patients in the HLA matched group and none of the three in the HLA mismatched group are surviving. Thirteen patients died: nine patients for causes directly or indirectly related to GvHD, four of other causes (relapse, rejection, hemorrhage and idiopathic interstitial pneumonia). Side effects of BMPr consisted in hyperglicemia, and steroid associated gastritis in 2/3 of the patients, both of which responded well to conventional treatment.

This study indicates that high dose BMPr is an effective form of treatment for established acute GvHD, and has no major side effects. The efficacy of BMPr is less clear in recipients of HLA mismatched grafts.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bacigalupo A, Van Lint MT, Cerri R et al. (1980) Treatment of severe aplastic anemia with bolus 6 methylprednisolone and antilymphocytic globulin. Blut 41: 168–171
    Google Scholar
  2. Bacigalupo A, Van Lint MT, Volta C et al. (1981) Tobramycin versus gentamicin in combination with cephalotin and carbenecillin. Tumori 67: 525–532
    Google Scholar
  3. Bolton WK, Couser VC (1979) Intravenouse pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am J Med 66: 495–498
    Google Scholar
  4. Clift RA, Hansen JA, Thomas ED et al. (1979) Marrow transplantation from donors other than identical siblings. Transplantation 28: 235–242
    Google Scholar
  5. Doney KC, Weiden PL, Storb R, Thomas ED (1981) Treatment of graft versus host disease in human allogeneic marrow graft recipients: a randomized trial comparing ATG and cortico-steroids. Am J Hematol 11: 1–8
    Google Scholar
  6. Gluckman E, Barret AJ, Arcese W, Devergie A, Degoulet P (1981) Bone marrow transplantation in severe aplastic anaemia. Br J Haematol 49: 165–173
    Google Scholar
  7. Gluckman E, Devergie A, Schaison G et al. (1980) Bone marrow transplantation in Fanconi anemia. Br J Haematol 45: 557–564
    Google Scholar
  8. Glucksberg H, Storb R, Fefer A et al. (1974) Clinical manifestations of graft versus host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 18: 295–304
    Google Scholar
  9. Gratwohl A, Osterwalder B, Ruggero D, Nissen C, Cornu P, Speck B (1980) Prophylaxis of graft versus host disease with cyclosporin A. Blut 41: 180–181
    Google Scholar
  10. Marmont AM (1979) Transplantation hemopoiesis. Nouv Rev Fr Hematol 21: 133–148
    Google Scholar
  11. Marmont AM, Damasio EE, Bacigalupo A et al. (1977) A to 0 bone marrow transplantation in severe aplastic anaemia. Br J Haematol 36: 511–518
    Google Scholar
  12. Marmont AM, Van Lint MT, Avanzi G et al. (1979) Bone marrow transplantation for severe aplastic anemia and leukemia: the Genova experience. In Lucarelli G, Fliedner TM, Gale RP (eds) Fetal liver transplantation. Elsevier-North Holland, Amsterdam New York
    Google Scholar
  13. Owens AH, Santos GW (1971) The effect of cytotoxic drugs on graft versus host disease in mice. Transplantation 11: 378–382
    Google Scholar
  14. Powles RL, Barret AJ, Clink H, Kay HM (1978) Cyclosporin A for treatment of graft versus host disease in man. Lancet II: 1327–1321
    Google Scholar
  15. Powles RL, Clink H, Spence D et al. (1980) Cyclosporin A to prevent graft versus host disease in man after allogeneic marrow transplantation. Lancet I: 327–329
    Google Scholar
  16. Prentice HG, Bateman SM, Bradstock KF, Hoffbrand AV (1980) High dose methylprednisolone therapy in established acute graft versus host disease. Blut 41: 175–177
    Google Scholar
  17. Schulman HM, McDonald GB, Matthexs D et al. (1970) Analysis of veno occlusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79: 1178–1191
    Google Scholar
  18. Simonsen M (1962) Graft versus host reactions. Their natural history and applicability as tools of research. Prog Allergy 6: 349–467
    Google Scholar
  19. Slavin RE, Santos GW (1973) The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implications. Clin Immunol Immunopathol 1: 472–493
    Google Scholar
  20. Storb R, Epstein RB, Graham TG et al. (1970) Methotrexate regimens for control of graft versus host disease in dogs with allogeneic marrow grafts. Transplantation 9: 240–246
    Google Scholar
  21. Storb R, Gluckman E, Thomas ED (1974) Treatment of established human graft versus host disease by antithymocyte globulin. Blood 44: 57–75
    Google Scholar
  22. Storb R, Prentice RL, Thomas ED (1977) Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. J Clin Invest 59: 625–632
    Google Scholar
  23. Storb R, Weiden PL, Deeg HJ, Torck-Storb B, Atkinson K, Graham TC, Thomas ED (1980) Marrow graft studies in dogs. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of Bone Marrow Transplantation. Haematology and Blood Transfusion, vol 25. Springer, Berlin Heidelberg New York, pp 43–52
    Google Scholar
  24. Thomas ED, Storb R, Clift RA et al. (1975) Bone marrow transplantation. N Engl J Med 292: 832–843
    Google Scholar
  25. Trotter JL, Garvey WF (1980) Prolonged effects of large dose methylprednisolone infusion in multiple sclerosis. Neurology 30: 702–708
    Google Scholar
  26. Tutschka PJ, Farmer E, Berschorner WE et al. (1981) Therapy of acute graft versus host disease. Exp Hematol [Suppl] 9: 126
    Google Scholar
  27. Van Bekkum DW (1974) The double barrier in bone marrow transplantation. Semin Hematol 11: 325–340
    Google Scholar
  28. Weiden PL, Doney K, Storb R et al. (1979) Antihuman thymocyte globulin for prophylaxis of graft versus host disease. Transplantation 27: 227–230
    Google Scholar
  29. Woods JE, Anderson CF, De Weerd JH et al. (1973) High dosage intravenously administered methylprednisolone in renal transplantation. JAMA 223: 896–899
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Ospedale San Martino, 1-16132, Genova, Italy
    Andrea Bacigalupo, Maria T. van Lint, Francesco Frassoni, Marina Podesta, Giovanna Veneziano, Giorgio Avanzi, Vito Vitale & Alberto M. Marmont

Authors

  1. Andrea Bacigalupo
  2. Maria T. van Lint
  3. Francesco Frassoni
  4. Marina Podesta
  5. Giovanna Veneziano
  6. Giorgio Avanzi
  7. Vito Vitale
  8. Alberto M. Marmont

Additional information

Supported by the Italian National Research Council (CNR) CT 81.01407.96 Progetto Finalizzato Controllo Crescita Neoplastica

Rights and permissions

About this article

Cite this article

Bacigalupo, A., van Lint, M.T., Frassoni, F. et al. High dose bolus methylprednisolone for the treatment of acute graft versus host disease.Blut 46, 125–132 (1983). https://doi.org/10.1007/BF00320270

Download citation

Key words